Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials.

Infect Dis Ther · 2021 · PMC7955009 · PMID 33515414

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The subanalysis from the DISCOVER 1 and DISCOVER 2 trials did not reach statistical significance likely as a result of the small sample size [ 25 ]; safety data from a larger cohort of vancomycin-treated patients on at least 10 days of vancomycin with available SCr values would help strengthen the conclusions drawn from our analysis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.